Product Information
DROXIDOPA 200 MG CAPSULE is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $1.6733 per EA under NDC 63304010490. Its NADAC has been published 149 times since Feb 22, 2023.
The High Outlier badge above means this manufacturer's average price in the droxidopa market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 ug/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
63304010490
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
2/18/2026
Active Ingredients
DROXIDOPAApproval Type
Generic (ANDA)
FDA Application
ANDA214384On Market Since
2/18/2021
Pharmacological Classes
Price Statistics
The NADAC for DROXIDOPA 200 MG CAPSULE has been published 149 times since Feb 22, 2023, and over the history we have for it it has declined 21.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.6733 per EA |
|---|---|
| All-time high | $2.3453 (Jul 10, 2024) |
| All-time low | $1.2814 (Apr 23, 2025) |
| 52-week high | $1.7346 |
| 52-week low | $1.4154 |
| Median price | $1.8279 |
| Average price | $1.8446 |
| Largest weekly change | -25.1% (Jul 17, 2024) |
| Weeks tracked | 149 |
| Tracking since | Feb 22, 2023 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 32% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DROXIDOPA 200 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DROXIDOPA 200 MG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $1.6733 per EA (NDC 63304010490), effective Feb 18, 2026.
How has the price of DROXIDOPA 200 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DROXIDOPA 200 MG CAPSULE has declined 21.4%. It has been tracked across 149 weekly CMS publications since Feb 22, 2023.
What are the highest and lowest recorded NADAC prices for DROXIDOPA 200 MG CAPSULE?
Since Feb 22, 2023, the NADAC for DROXIDOPA 200 MG CAPSULE has ranged from a low of $1.2814 (Apr 23, 2025) to a high of $2.3453 (Jul 10, 2024), with a median of $1.8279 per EA.
Are there cheaper alternatives to DROXIDOPA 200 MG CAPSULE?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DROXIDOPA 200 MG CAPSULE, is $1.1305 per EA — about 32% below DROXIDOPA 200 MG CAPSULE.
Who manufactures DROXIDOPA 200 MG CAPSULE?
DROXIDOPA 200 MG CAPSULE (NDC 63304010490) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification